Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Researchers found that combining cardiovascular disease drug classes, particularly antihypertensives, can reduce risk of dementia.

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

Antibiotic use was not associated with an increased risk of cognitive impairment and dementia in healthy older adults, ...

Alzheimer’s disease and other dementias can cause people to lose their ability to recognise people and places that are ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to ...

But that doesn't mean they have to come off the drugs. As with all pills, it's about weighing the pros and cons. Quite aside from the dementia worries, if a patient ... shock is used to stimulate ...

This University of Waterloo study shows how antipsychotic medications significantly worsened behavior in nursing home ...

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

In this prognostic study, with the use of a statistical modeling approach, the Florey Dementia Index was developed and validated to predict the onset age of mild cognitive impairment and Alzheimer ...